从PATHOS看慢阻肺管理__培训课件.pptVIP

* Compared with FLU/SAL Diskus, BUD/FOR Turbuhalor was associated with reduced risk : of all kind of exacerbations by 26 % (26,6%), here presented as event/100 patient/year; 80/100 vs 109/100: NNT = 3.4 Budesonide/formoterol had 26.0% fewer oral steroid courses and 29.0% fewer antibiotic courses reduced risk of hospitalizations due to COPD by 29% and 21.0% lower risk for ER visits in the budesonide/formoterol treatment group All highly significant The mean collected budesonide dose was 568μg/day for matched patients who were prescribed budesonide/formoterol and the mean fluticasone d